![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Aksoy S, Celikkanat H, Senoz S, Gokmen P. 1996. The prognostic value of serum estradiol, progesterone, testosterone, and free testosterone levels in detecting early abortions. European Journal of Obstetrics and Gynecology and Reproductive Biology 67:5–8.
- Blohm F, Friden B, Milsom I. 2008. A prospective longitudinal population-based study of clinical miscarriage in an urban Swedish population. British Journal of Obstetrics and Gynaecology115:176–182.
- Carp H. 2012. A systematic review of dydrogesterone for the treatment of threatened miscarriage. Gynecological Endocrinology 28:983–990.
- Cunningham FG. 2001. Physiology of pregnancy. In: Gary Cunningham F, Wenstrom K, Hauth J, Leveno K, editors. Williams obstetrics. 21st ed. New York (NY): McGraw-Hill. p. 13–31.
- Daya S. 1989. Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta-analysis of controlled trials. British Journal of Obstetrics and Gynaecology 96:275–280.
- Dodd JM, Flenady VJ, Cincotta R, Crowther CA. 2008. Progesterone for the prevention of preterm birth: a systematic review. Obstetrics and Gynecology 112:127–134.
- Haas DM, Ramsey PS. 2008. Progestogen for preventing miscarriage. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD003511.pub2.
- Haas DM, Ramsey PS. 2013. Progestogen for preventing miscarriage. Cochrane Database Systematic Reviews 10:CD003511.
- Herbert D, Lucke J, Dobson A. 2009. Pregnancy losses in young Australian women: findings from the Australian longitudinal study on women's health. Womens Health Issues 19:21–29.
- Hou SP, Fang AH, Chen QF, Huang YM, Chen OJ, Cheng LN. 2011. Termination of second-trimester pregnancy by mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate (Rivanol®): a systematic review of Chinese trials. Contraception 84:214–223.
- Huisjes HJ, Lind T. 1990. Early pregnancy failure. Edinburgh: Churchill Livingstone.
- Jin S, Li SW, Long J, Li L, Tan ZJ. 2006. The role of progesterone in human early pregnancy is mediated by insulin-like growth factors binding protein1-3. Sichuan Da Xue Xue Bao Yi Xue Ban 37:399–403.
- Kalinka J, Szekeres-Bartho J. 2005. The impact of dydrogesterone supplementation on hormonal profile and progesterone- induced blocking factor concentrations in women with threatened abortion. American Journal of Reproductive Immunology 53:166–171.
- Keirse MJ. 1990. Progestogen administration in pregnancy may prevent preterm delivery. British Journal of Obstetrics and Gynaecology 97:149–154.
- McBride WZ. 1991. Spontaneous abortion. American Family Physician 43:175–182.
- Osmanagaoglu MA, Erdogan I, Eminagaoglu S, Karahan SC, Ozgün S, Can G, Bozkaya H. 2010. The diagnostic value of beta-human chorionic gonadotropin, progesterone, CA125 in the prediction of abortions. Journal of Obstetrics and Gynaecology 30:288–293.
- Palagiano A, Bulletti C, Pace MC, De Ziegler D, Cicinelli E, Izzo A. 2004. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences 1034:200–210.
- Sotiriadis A, Papatheodorou S, Makrydimas G. 2004. Threatened miscarriage: evaluation and management. British Medical Journal 329:152–155.
- Suzumori N, Sugiura-Ogasawara M. 2010. Genetic factors as a cause of miscarriage. Current Medicinal Chemistry 17:3431–3437.
- Szekeres-Bartho J. 2009. Progesterone-mediated immunomodulation in pregnancy: its relevance to leukocyte immunotherapy of recurrent miscarriage. Immunotherapy 1:873–882.
- Szekeres-Bartho J, Wilczynski JR, Basta P, Kalinka J. 2008. Role of progesterone and progestin therapy in threatened abortion and preterm labour. Frontiers in Bioscience 13:1981–1990.
- Tang OS, Chan CC, Ng EH, Lee SW, Ho PC. 2003. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Human Reproduction 18:2315–2318.
- Vorsanova SG, Kolotii AD, Iourov IY, Monakhov VV, Kirillova EA, Soloviev IV. 2005. Evidence for high frequency of chromosomal mosaicism in spontaneous abortions revealed by interphase FISH analysis. Journal of Histochemistry and Cytochemistry 53:375–380.
- Wahabi HA, Fayed AA, Esmaeil SA, Al Zeidan RA. 2011. Progestogen for treating threatened miscarriage. Cochrane Database Systematic Reviews CD005943. doi:10.1002/14651858.CD005943.pub4.